Tirzepatide for Anxiety: What the Evidence Shows
What human and animal studies show about Tirzepatide for anxiety, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Human RCT
- Human studies
- 13
- PubMed records, our ledger
- Animal studies
- 1
- PubMed records, our ledger
- Studies we summarised
- 1
- with an outcome for anxiety
Evidence for anxiety
Each row is an outcome related to anxiety from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Depressive symptoms (PHQ-9) | Fewer tirzepatide participants shifted to a more severe depressive-symptom category (18.2% vs 24.3% with placebo). | Human RCTn = 4056 | Obesity 2026, PMID 41537305 |
PubMed records for Tirzepatide and anxiety: 13 human, 1 animal (search counts, not studies we reviewed). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What was measured: depression scores and suicidality, not anxiety
MedlinePlus defines anxiety as a feeling of fear, dread and uneasiness that can be a normal reaction to stress.[2]
No randomised trial of tirzepatide for anxiety was found. The nearest controlled data are a post hoc analysis of depressive symptoms and suicidal ideation in 4056 participants on tirzepatide or placebo.[1]
In that analysis depression scores at week 72 were slightly lower with tirzepatide than placebo, and fewer people moved to a worse depression category.[1]
Safety signals and social-media chatter
The same analysis found suicidal ideation in 0.6% of participants in each group, and nonfatal suicidal behaviour in 0.1% on tirzepatide against none on placebo.[1]
A study of Facebook mentions found anxiety, depression and insomnia were highly correlated with each other among GLP-1 drug adverse-event mentions. This is social-media data and shows co-mention, not cause.[3]
The Mounjaro patient information lists anxiety, irritability or mood changes among the symptoms of low blood sugar.[4]
Other peptides people research for anxiety
All peptides for anxiety, comparedCommon questions
Does Tirzepatide help with anxiety?
The strongest study we summarise for anxiety is human rct evidence, across 1 study with an outcome for anxiety. A trial result is not an approval; see the legal status.
Is Tirzepatide approved for anxiety?
Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for anxiety?
There is no single answer. Our anxiety overview compares each candidate by evidence grade and legal status rather than by popularity.
Does tirzepatide cause anxiety?
The Mounjaro leaflet lists anxiety, irritability or mood changes as signs of low blood sugar; no anxiety result from a tirzepatide trial is cited here.[4]
Can tirzepatide help with anxiety?
No trial of tirzepatide for anxiety is cited here. In a post hoc analysis of obesity trials, tirzepatide did not appear to be associated with an increased risk of depression.[1]
More on Tirzepatide
Sources
- 1Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.Obesity (Silver Spring, Md.) · 2026PMID 41537305Accessed 2 Oct 2026
- 2Official web pageOfficial web page · web page
- 3Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024.JMIR infodemiology · 2025PMID 40706081Accessed 2 Oct 2026
- 4MOUNJARO prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
Found an error? Report a correction.